Insider Trading activities of Inverness Medical Innovations Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inverness Medical Innovations Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inverness Medical Innovations Inc since year 2005. Table 2 shows the detailed insider transactions of Inverness Medical Innovations Inc since 2005. The reporting company's ticker symbol is ALR. The reporting company's CIK number is 1145460.
The total value of stock buying since 2005 is $5,385,025.
The total value of stock sales since 2005 is $44,896,608.
The total value of stock option exercises since 2005 is $37,819,549.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Inverness Medical Innovations Inc (ALR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 0 $0 61,669 $534,894
2017-06 0 $0 0 $0 44,240 $0
2017-04 0 $0 0 $0 16,667 $0
2017-02 0 $0 0 $0 149,029 $0
2017-01 0 $0 0 $0 53,334 $0
2016-12 0 $0 0 $0 40,000 $1,548,000
2016-10 0 $0 0 $0 43,167 $995,100
2016-09 0 $0 0 $0 68,334 $0
2016-02 0 $0 2,500 $135,000 9,166 $84,324
2015-12 0 $0 0 $0 100,000 $0
2015-11 11,000 $438,690 0 $0 0 $0
2015-10 0 $0 0 $0 16,666 $0
2015-09 0 $0 12,786 $657,988 5,000 $93,900
2015-08 20,000 $986,580 58,973 $3,154,775 113,969 $1,750,276
2015-06 0 $0 47,500 $2,439,215 47,500 $1,162,150
2015-05 0 $0 22,564 $1,154,487 47,564 $1,503,577
2015-04 0 $0 5,531 $269,912 30,531 $862,910
2015-03 0 $0 46,976 $2,281,196 46,976 $1,687,061
2015-02 0 $0 13,292 $593,341 12,500 $350,375
2015-01 0 $0 10,000 $424,450 10,000 $231,500
2014-12 0 $0 50,000 $1,853,400 55,000 $1,212,500
2014-08 0 $0 10,000 $350,700 10,000 $242,500
2013-12 0 $0 8,547 $288,264 32,247 $635,763
2013-11 0 $0 4,576 $154,371 12,152 $264,669
2013-08 0 $0 22,500 $740,030 22,500 $583,175
2013-05 0 $0 8,750 $226,240 8,750 $222,512
2013-03 0 $0 23,686 $554,434 27,500 $445,500
2012-08 0 $0 12,712 $240,744 11,872 $140,069
2012-07 0 $0 4,752 $95,040 4,752 $55,836
2012-06 0 $0 10,113 $192,288 18,294 $291,017
2012-05 0 $0 0 $0 1,805 $28,158
2012-04 0 $0 0 $0 3,486 $40,960
2012-03 0 $0 4,357 $108,925 4,357 $51,194
2012-02 0 $0 13,004 $326,409 13,004 $158,166
2011-11 0 $0 298,295 $7,321,353 824,967 $14,266,273
2011-08 7,944 $180,980 0 $0 0 $0
2011-04 0 $0 0 $0 11,650 $218,204
2011-03 0 $0 19,209 $705,988 25,856 $399,992
2011-02 0 $0 0 $0 52,065 $1,371,499
2011-01 0 $0 0 $0 78,051 $2,078,072
2010-11 0 $0 1,020 $29,804 2,000 $29,160
2010-08 850 $24,480 0 $0 0 $0
2010-07 5,000 $141,490 0 $0 0 $0
2010-06 0 $0 0 $0 1,591 $7,097
2010-05 0 $0 1,145 $42,407 2,700 $18,103
2010-04 0 $0 3,486 $87,150 0 $0
2010-02 0 $0 8,333 $328,320 8,333 $233,573
2009-09 0 $0 0 $0 5,784 $7,924
2009-06 0 $0 87,700 $2,862,055 115,000 $920,350
2009-02 0 $0 25,000 $598,150 25,000 $468,250
2008-12 2,000 $33,000 5,000 $85,115 0 $0
2008-11 119,555 $1,739,439 100,000 $1,428,900 51,787 $540,656
2008-06 32,600 $1,190,815 0 $0 0 $0
2008-03 21,233 $649,551 0 $0 0 $0
2008-02 0 $0 0 $0 14,150 $251,997
2008-01 0 $0 42,000 $2,478,084 42,000 $255,360
2007-12 0 $0 10,000 $570,574 12,503 $69,868
2007-11 0 $0 165,698 $9,806,006 37,910 $512,751
2007-08 0 $0 41,667 $1,998,765 41,667 $974,174
2006-08 0 $0 0 $0 4,800 $20,160
2006-06 25,000 $0 0 $0 0 $0
2005-06 0 $0 11,263 $312,728 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Inverness Medical Innovations Inc insiders (ALR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-31 Gladwell Mark (Senior VP, Global Operations) Option Ex 5,000 .00 0
2017-08-31 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 8,334 .00 0
2017-08-31 Cramp Daniella (Global Pres., Cardiometabolic) Option Ex 16,667 32.09 534,894
2017-08-31 Malkani Sanjay (Global Pres., Toxicology) Option Ex 6,667 .00 0
2017-08-31 Chiniara Ellen (GC, Chief Ethics Officer&Sec) Option Ex 6,667 .00 0
2017-08-31 Hargadon Robert Bernard (SVP, Global Human Resources) Option Ex 6,667 .00 0
2017-08-31 Pelossof Avi (GlobalPres, Infectious Disease) Option Ex 6,667 .00 0
2017-08-31 Bridgen John (Sr VP, Business Develop) Option Ex 5,000 .00 0
2017-06-30 Ginsburg Geoffrey S Option Ex 5,530 .00 0
2017-06-30 Powers Gregg J Option Ex 5,530 .00 0
2017-06-30 Mckillop Thomas Option Ex 5,530 .00 0
2017-06-30 Roosevelt James Jr. Option Ex 5,530 .00 0
2017-06-30 Markison Brian A Option Ex 5,530 .00 0
2017-06-30 Levy John F Option Ex 5,530 .00 0
2017-06-30 Quelch John Option Ex 5,530 .00 0
2017-06-30 Goldberg Carol R Option Ex 5,530 .00 0
2017-04-06 Hinrichs James F. (Executive VP, CFO) Option Ex 16,667 .00 0
2017-02-28 Uppaluri Renuka (Senior VP, Global R&D) Option Ex 6,667 .00 0
2017-02-16 Uppaluri Renuka (Senior VP, Global R&D) Option Ex 8,163 .00 0
2017-02-16 Gladwell Mark (Senior VP, Global Operations) Option Ex 8,163 .00 0
2017-02-16 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 9,736 .00 0
2017-02-16 Cramp Daniella (Global Pres., Cardiometabolic) Option Ex 9,736 .00 0
2017-02-16 Malkani Sanjay (Global Pres., Toxicology) Option Ex 9,736 .00 0
2017-02-16 Nawana Namal (Chief Executive Officer) Option Ex 47,188 .00 0
2017-02-16 Hinrichs James F. (Executive VP, CFO) Option Ex 13,842 .00 0
2017-02-16 Chiniara Ellen (GC, Chief Ethics Officer&Sec) Option Ex 9,736 .00 0
2017-02-16 Hargadon Robert Bernard (SVP, Global Human Resources) Option Ex 8,163 .00 0
2017-02-16 Pelossof Avi (GlobalPres, Infectious Disease) Option Ex 9,736 .00 0
2017-02-16 Bridgen John (Sr VP, Business Develop) Option Ex 8,163 .00 0
2017-01-15 Wygant Jonathan (VP, Controller, CAO) Option Ex 3,334 .00 0
2017-01-15 Nawana Namal (Chief Executive Officer) Option Ex 50,000 .00 0
2016-12-30 Pelossof Avi (GlobalPres, Infectious Disease) Option Ex 40,000 38.70 1,548,000
2016-10-31 Nawana Namal (Chief Executive Officer) Option Ex 16,667 .00 0
2016-10-14 Chiniara Ellen (GC, Chief Ethics Officer&Sec) Option Ex 25,000 37.74 943,500
2016-10-03 Gladwell Mark (Senior VP, Global Operations) Option Ex 1,500 34.40 51,600
2016-09-09 Gladwell Mark (Senior VP, Global Operations) Option Ex 5,000 .00 0
2016-09-09 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 8,333 .00 0
2016-09-09 Cramp Daniella (Global Pres., Cardiometabolic) Option Ex 6,667 .00 0
2016-09-09 Malkani Sanjay (Global Pres., Toxicology) Option Ex 6,667 .00 0
2016-09-09 Hinrichs James F. (Executive VP, CFO) Option Ex 16,666 .00 0
2016-09-09 Chiniara Ellen (GC, Chief Ethics Officer&Sec) Option Ex 6,667 .00 0
2016-09-09 Hargadon Robert Bernard (SVP, Global Human Resources) Option Ex 6,667 .00 0
2016-09-09 Pelossof Avi (GlobalPres, Infectious Disease) Option Ex 6,667 .00 0
2016-09-09 Bridgen John (Sr VP, Business Develop) Option Ex 5,000 .00 0
2016-02-28 Uppaluri Renuka (Senior VP, Global R&D) Option Ex 6,666 .00 0
2016-02-01 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 2,500 54.00 135,000
2016-02-01 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 2,500 33.73 84,324
2015-12-30 Nawana Namal (Chief Executive Officer) Option Ex 100,000 .00 0
2015-11-13 Hargadon Robert Bernard (SVP, Global Human Resources) Buy 1,000 38.99 38,990
2015-11-12 Hinrichs James F. (Executive VP, CFO) Buy 10,000 39.97 399,700
2015-10-31 Nawana Namal (Chief Executive Officer) Option Ex 16,666 .00 0
2015-09-03 Gladwell Mark (Senior VP, Global Operations) Sale 2,651 52.27 138,554
2015-09-03 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 5,135 52.00 267,020
2015-09-01 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 5,000 50.48 252,414
2015-09-01 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 5,000 18.78 93,900
2015-08-31 Gladwell Mark (Senior VP, Global Operations) Sale 27,513 52.23 1,437,059
2015-08-31 Gladwell Mark (Senior VP, Global Operations) Option Ex 32,513 19.63 638,165
2015-08-31 Flakne Carla (VP, Chief Accounting Officer) Option Ex 3,333 .00 0
2015-08-31 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 8,333 .00 0
2015-08-31 Cramp Daniella (Global Pres., Cardiometabolic) Option Ex 6,666 .00 0
2015-08-31 Malkani Sanjay (Global Pres., Toxicology) Option Ex 6,666 .00 0
2015-08-31 Chiniara Ellen (GC, Chief Ethics Officer&Sec) Option Ex 6,666 .00 0
2015-08-31 Hargadon Robert Bernard (SVP, Global Human Resources) Option Ex 6,666 .00 0
2015-08-31 Pelossof Avi (GlobalPres, Infectious Disease) Option Ex 6,666 .00 0
2015-08-31 Bridgen John (Sr VP, Business Develop) Option Ex 5,000 .00 0
2015-08-14 Malkani Sanjay (Global Pres., Toxicology) Sale 31,460 54.60 1,717,716
2015-08-14 Malkani Sanjay (Global Pres., Toxicology) Option Ex 31,460 35.35 1,112,111
2015-08-07 Hinrichs James F. (Executive VP, CFO) Buy 20,000 49.33 986,580
2015-06-08 Malkani Sanjay (Global Pres., Toxicology) Sale 24,331 50.87 1,237,644
2015-06-08 Malkani Sanjay (Global Pres., Toxicology) Option Ex 24,331 19.18 466,546
2015-06-04 Malkani Sanjay (Global Pres., Toxicology) Sale 15,669 52.18 817,639
2015-06-04 Malkani Sanjay (Global Pres., Toxicology) Option Ex 15,669 31.92 500,154
2015-06-01 Bridgen John (Sr VP, Business Develop) Sale 7,500 51.19 383,932
2015-06-01 Bridgen John (Sr VP, Business Develop) Option Ex 7,500 26.06 195,450
2015-05-29 Bridgen John (Sr VP, Business Develop) Sale 22,564 51.16 1,154,487
2015-05-29 Bridgen John (Sr VP, Business Develop) Option Ex 22,564 35.58 802,827
2015-05-22 Quelch John Option Ex 25,000 28.03 700,750
2015-04-30 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 3,031 47.81 144,912
2015-04-30 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 3,031 25.68 77,836
2015-04-20 Levy John F Option Ex 25,000 28.03 700,750
2015-04-06 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 2,500 50.00 125,000
2015-04-06 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 2,500 33.73 84,324
2015-03-23 Guerdan Melissa (SVP, Global Quality & Reg.) Sale 13,476 48.34 651,497
2015-03-23 Guerdan Melissa (SVP, Global Quality & Reg.) Option Ex 13,476 22.23 299,571
2015-03-17 Bridgen John (Sr VP, Business Develop) Sale 25,000 48.53 1,213,250
2015-03-17 Bridgen John (Sr VP, Business Develop) Option Ex 25,000 42.26 1,056,500
2015-03-16 Flakne Carla (VP, Chief Accounting Officer) Sale 8,500 48.99 416,449
2015-03-16 Flakne Carla (VP, Chief Accounting Officer) Option Ex 8,500 38.94 330,990
2015-02-23 Gladwell Mark (Senior VP, Global Operations) Sale 13,292 44.64 593,341
2015-02-23 Gladwell Mark (Senior VP, Global Operations) Option Ex 12,500 28.03 350,375
2015-01-16 Flakne Carla (VP, Chief Accounting Officer) Sale 10,000 42.45 424,450
2015-01-16 Flakne Carla (VP, Chief Accounting Officer) Option Ex 10,000 23.15 231,500
2014-12-30 Nawana Namal (Chief Executive Officer) Option Ex 5,000 .00 0
2014-12-11 Bridgen John (Sr VP, Business Develop) Sale 50,000 37.07 1,853,400
2014-12-11 Bridgen John (Sr VP, Business Develop) Option Ex 50,000 24.25 1,212,500
2014-08-15 Teitel Dave (Chief Financial Officer) Sale 10,000 35.07 350,700
2014-08-15 Teitel Dave (Chief Financial Officer) Option Ex 10,000 24.25 242,500
2013-12-30 Nawana Namal (Chief Operating Officer) Option Ex 5,000 .00 0
2013-12-16 Scott David (Chief Scientific Officer) Option Ex 5,252 21.78 114,388
2013-12-12 Bridgen John (Sr VP, Business Develop) Option Ex 6,664 21.78 145,141
2013-12-12 Mcaleer Jerome F (Sr. VP, Research & Development) Option Ex 4,656 21.78 101,407
2013-12-11 Torchilin Kate (VP, Connected Health) Sale 8,547 33.73 288,264
2013-12-11 Torchilin Kate (VP, Connected Health) Option Ex 10,675 25.75 274,827
2013-11-13 Hempel Paul T (SVP Ethics & Compliance) Sale 921 33.68 31,015
2013-11-13 Hempel Paul T (SVP Ethics & Compliance) Option Ex 921 21.78 20,059
2013-11-12 Hempel Paul T (SVP Ethics & Compliance) Sale 3,655 33.75 123,356
2013-11-12 Hempel Paul T (SVP Ethics & Compliance) Option Ex 3,655 21.78 79,605
2013-11-01 Zwanziger Ron (Chairman, CEO & President) Option Ex 7,576 21.78 165,005
2013-08-15 Teitel Dave (Chief Financial Officer) Sale 10,000 31.73 317,280
2013-08-15 Teitel Dave (Chief Financial Officer) Option Ex 10,000 21.38 213,800
2013-08-05 Cotton Michael Lester (Global Pres, Health Mgmt) Sale 12,500 33.82 422,750
2013-08-05 Cotton Michael Lester (Global Pres, Health Mgmt) Option Ex 12,500 29.55 369,375
2013-05-31 Cotton Michael Lester (Global Pres, Health Mgmt) Sale 8,750 25.86 226,240
2013-05-31 Cotton Michael Lester (Global Pres, Health Mgmt) Option Ex 8,750 25.43 222,512
2013-03-07 Post Jim (President, Acute Care) Sale 1,075 23.37 25,122
2013-03-05 Quelch John Sale 20,220 23.50 475,068
2013-03-05 Quelch John Option Ex 25,000 16.20 405,000
2013-03-01 Eylenbosch Hilde (President, Alere International) Sale 2,391 22.69 54,244
2013-03-01 Eylenbosch Hilde (President, Alere International) Option Ex 2,500 16.20 40,500
2012-08-23 Post Jim (President, Alere NA) Sale 840 18.77 15,766
2012-08-14 Toohey David (President, Intl Bus. Operation) Sale 151 18.28 2,760
2012-08-14 Toohey David (President, Intl Bus. Operation) Option Ex 151 15.55 2,348
2012-08-07 Bridgen John (Sr VP, Business Develop) Sale 11,721 18.96 222,218
2012-08-07 Bridgen John (Sr VP, Business Develop) Option Ex 11,721 11.75 137,721
2012-07-19 Bridgen John (VP, Strategic Business Develop) Sale 4,752 20.00 95,040
2012-07-19 Bridgen John (VP, Strategic Business Develop) Option Ex 4,752 11.75 55,836
2012-06-14 Zwanziger Ron (Chairman, CEO & President) Option Ex 5,065 15.55 78,760
2012-06-13 Hempel Paul T (SVP Ethics & Compliance) Sale 10,113 19.01 192,288
2012-06-13 Hempel Paul T (SVP Ethics & Compliance) Option Ex 10,913 16.15 176,244
2012-06-05 Hart Emanuel (President, LAmARCIS) Option Ex 2,316 15.55 36,013
2012-05-29 Mcaleer Jerome F (VP, Research & Development) Option Ex 1,805 15.60 28,158
2012-04-26 Bridgen John (VP, Strategic Business Develop) Option Ex 3,486 11.75 40,960
2012-03-07 Bridgen John (VP, Strategic Business Develop) Sale 4,357 25.00 108,925
2012-03-07 Bridgen John (VP, Strategic Business Develop) Option Ex 4,357 11.75 51,194
2012-02-16 Underwood Thomas (CEO, Alere Health LLC) Sale 750 26.02 19,515
2012-02-16 Underwood Thomas (CEO, Alere Health LLC) Option Ex 750 18.91 14,182
2012-02-07 Bridgen John (VP, Strategic Business Develop) Sale 5,446 25.10 136,694
2012-02-07 Bridgen John (VP, Strategic Business Develop) Option Ex 5,446 11.75 63,990
2012-02-02 Bridgen John (VP, Strategic Business Develop) Sale 6,808 25.00 170,200
2012-02-02 Bridgen John (VP, Strategic Business Develop) Option Ex 6,808 11.75 79,994
2011-11-28 Mcaleer Jerome F (VP, Research & Development) Sale 116,829 22.25 2,599,211
2011-11-28 Mcaleer Jerome F (VP, Research & Development) Option Ex 129,413 16.76 2,168,961
2011-11-22 Mcaleer Jerome F (VP, Research & Development) Option Ex 351,840 19.32 6,796,845
2011-11-21 Zwanziger Ron (Chairman, CEO & President) Option Ex 101,794 16.27 1,656,188
2011-11-16 Scott David (Chief Technical Officer) Sale 164,237 26.02 4,273,775
2011-11-16 Scott David (Chief Technical Officer) Option Ex 199,691 14.57 2,909,497
2011-11-15 Eylenbosch Hilde (Chief Commercial Officer) Sale 17,229 26.02 448,367
2011-11-15 Eylenbosch Hilde (Chief Commercial Officer) Option Ex 17,229 15.47 266,532
2011-11-01 Levy John F Option Ex 25,000 18.73 468,250
2011-08-23 Roosevelt James Jr. Buy 4,444 22.50 99,990
2011-08-11 Underwood Thomas (CEO, Alere Health LLC) Buy 1,500 23.44 35,160
2011-08-09 Hargadon Robert Bernard (VP, Global Culture & Performan) Buy 2,000 22.91 45,830
2011-04-21 Goldberg Carol R Option Ex 11,650 18.73 218,204
2011-03-15 Hempel Paul T (SVP Ethics & Compliance) Sale 19,209 36.75 705,988
2011-03-15 Hempel Paul T (SVP Ethics & Compliance) Option Ex 25,856 15.47 399,992
2011-02-25 Eylenbosch Hilde (Chief Commercial Officer) Option Ex 4,565 15.88 72,469
2011-02-08 Zwanziger Ron (Chairman, CEO & President) Option Ex 47,500 27.35 1,299,030
2011-01-27 Mcaleer Jerome F (VP, Research & Development) Option Ex 32,000 27.46 878,720
2011-01-27 Scott David (Chief Technical Officer) Option Ex 40,851 27.46 1,121,768
2011-01-26 Eylenbosch Hilde (Chief Commercial Officer) Option Ex 4,000 14.92 59,680
2011-01-19 Eylenbosch Hilde (Chief Commercial Officer) Option Ex 1,200 14.92 17,904
2010-11-12 Hempel Paul T (Sr VP, LD & Legal Affairs) Sale 1,020 29.22 29,804
2010-11-12 Hempel Paul T (Sr VP, LD & Legal Affairs) Option Ex 2,000 14.58 29,160
2010-08-27 Adashi Eli Buy 850 28.80 24,480
2010-07-30 Quelch John Buy 5,000 28.30 141,490
2010-06-17 Hart Emanuel (VP, Lat. Am., Africa & Russia) Option Ex 1,200 4.38 5,256
2010-06-04 Levy John F Option Ex 391 4.71 1,841
2010-05-17 Hempel Paul T (Sr VP, LD & Legal Affairs) Sale 1,145 37.04 42,407
2010-05-17 Hempel Paul T (Sr VP, LD & Legal Affairs) Option Ex 2,700 6.71 18,103
2010-04-26 Bridgen John (VP, Strategic Business Develop) Sale 3,486 25.00 87,150
2010-02-19 Townsend Peter Sale 8,333 39.40 328,320
2010-02-19 Townsend Peter Option Ex 8,333 28.03 233,573
2009-09-09 Hempel Paul T (Sr VP, LD & Legal Affairs) Option Ex 600 1.37 822
2009-09-08 Levy John F Option Ex 5,184 1.37 7,102
2009-06-16 Khederian Robert P Sale 25,000 32.74 818,575
2009-06-16 Khederian Robert P Option Ex 25,000 28.03 700,750
2009-06-16 Mcaleer Jerome F (VP, Research & Development) Sale 40,000 32.79 1,311,519
2009-06-16 Mcaleer Jerome F (VP, Research & Development) Option Ex 40,000 2.44 97,600
2009-06-16 Scott David (Chief Technical Officer) Sale 22,700 32.24 731,961
2009-06-16 Scott David (Chief Technical Officer) Option Ex 50,000 2.44 122,000
2009-02-26 Khederian Robert P Sale 25,000 23.93 598,150
2009-02-26 Khederian Robert P Option Ex 25,000 18.73 468,250
2008-12-01 Khederian Robert P Sale 5,000 17.02 85,115
2008-12-01 Bresson Michael K (VP, Mergers and Acquisitions) Buy 2,000 16.50 33,000
2008-11-24 Zwanziger Ron (Chairman, CEO & President) Buy 64,000 15.52 993,280
2008-11-21 Khederian Robert P Sale 20,000 14.14 282,900
2008-11-21 Mcaleer Jerome F (VP, Research & Development) Buy 55,555 13.43 746,159
2008-11-20 Khederian Robert P Sale 80,000 14.32 1,146,000
2008-11-03 Geraty Ronald D (CEO, Alere Medical, Inc.) Option Ex 51,787 10.44 540,656
2008-06-05 Khederian Robert P Buy 5,000 38.56 192,800
2008-06-02 Zwanziger Ron (Chairman, CEO & President) Buy 27,600 36.16 998,015
2008-03-05 Russell Jon (VP, Finance) Buy 200 30.11 6,022
2008-03-05 Jenkins Geoffrey (VP, Worldwide Operations) Buy 833 30.25 25,198
2008-03-04 Levy John F Buy 17,000 30.70 521,883
2008-03-04 Bresson Michael K (VP, Mergers and Acquisitions) Buy 2,500 30.00 75,000
2008-03-03 Teitel Dave (Chief Financial Officer) Buy 700 30.64 21,448
2008-02-29 Eylenbosch Hilde (President,Consumer Diagnostics) Option Ex 800 2.44 1,952
2008-02-22 Goldberg Carol R Option Ex 13,350 18.73 250,045
2008-01-08 Geraty Ronald D (CEO, Alere Medical, Inc.) Sale 42,000 59.00 2,478,084
2008-01-08 Geraty Ronald D (CEO, Alere Medical, Inc.) Option Ex 42,000 6.08 255,360
2007-12-26 Geraty Ronald D (CEO, Alere Medical, Inc.) Sale 3,400 57.17 194,374
2007-12-26 Geraty Ronald D (CEO, Alere Medical, Inc.) Option Ex 3,400 6.08 20,672
2007-12-24 Geraty Ronald D (CEO, Alere Medical, Inc.) Sale 6,600 57.00 376,200
2007-12-24 Geraty Ronald D (CEO, Alere Medical, Inc.) Option Ex 6,600 6.08 40,128
2007-12-05 Eylenbosch Hilde (President,Consumer Diagnostics) Option Ex 2,503 3.62 9,068
2007-11-20 Bridgen John (VP, Strategy for PD Cardiology) Sale 13,430 59.18 794,787
2007-11-20 Bridgen John (VP, Strategy for PD Cardiology) Option Ex 13,430 11.75 157,802
2007-11-20 Hempel Paul T (Sr VP, LD & Legal Affairs) Sale 11,000 59.18 650,980
2007-11-20 Hempel Paul T (Sr VP, LD & Legal Affairs) Option Ex 11,000 15.51 170,610
2007-11-20 Mcaleer Jerome F (VP, Research & Development) Sale 75,000 59.18 4,438,500
2007-11-20 Toohey David (Pres, Professional Diagnostics) Sale 13,480 59.18 797,746
2007-11-20 Toohey David (Pres, Professional Diagnostics) Option Ex 13,480 13.68 184,339
2007-11-20 Yonkin John (Pres., US Point of Care) Sale 8,000 59.18 473,440
2007-11-20 Scott David (Chief Technical Officer) Sale 44,788 59.18 2,650,553
2007-08-31 Townsend Peter Sale 41,667 47.97 1,998,765
2007-08-31 Townsend Peter Option Ex 41,667 23.38 974,174
2006-08-03 Goldberg Carol R Option Ex 2,400 4.14 9,936
2006-08-02 Levy John F Option Ex 2,400 4.26 10,224
2006-06-21 Eylenbosch Hilde (President,Consumer Diagnostics) Buy 25,000 .00 0
2005-06-06 Bernardo Anthony J (President, Binax, In) Sale 11,263 27.77 312,728

Insider trading activities including stock purchases, stock sales, and option exercises of ALR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inverness Medical Innovations Inc (symbol ALR, CIK number 1145460) see the Securities and Exchange Commission (SEC) website.